• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中子晶体学揭示 SARS-CoV-2 主蛋白酶的非寻常两性离子催化位点。

Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.

机构信息

Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA; National Virtual Biotechnology Laboratory, United States Department of Energy, Washington, DC, USA.

Neutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA; National Virtual Biotechnology Laboratory, United States Department of Energy, Washington, DC, USA; Second Target Station, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.

出版信息

J Biol Chem. 2020 Dec 11;295(50):17365-17373. doi: 10.1074/jbc.AC120.016154. Epub 2020 Oct 15.

DOI:10.1074/jbc.AC120.016154
PMID:33060199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7832724/
Abstract

The main protease (3CL M) from SARS-CoV-2, the etiological agent of COVID-19, is an essential enzyme for viral replication. 3CL M possesses an unusual catalytic dyad composed of Cys and His residues. A critical question in the field has been what the protonation states of the ionizable residues in the substrate-binding active-site cavity are; resolving this point would help understand the catalytic details of the enzyme and inform rational drug development against this pernicious virus. Here, we present the room-temperature neutron structure of 3CL M, which allowed direct determination of hydrogen atom positions and, hence, protonation states in the protease. We observe that the catalytic site natively adopts a zwitterionic reactive form in which Cys is in the negatively charged thiolate state and His is doubly protonated and positively charged, instead of the neutral unreactive state usually envisaged. The neutron structure also identified the protonation states, and thus electrical charges, of all other amino acid residues and revealed intricate hydrogen-bonding networks in the active-site cavity and at the dimer interface. The fine atomic details present in this structure were made possible by the unique scattering properties of the neutron, which is an ideal probe for locating hydrogen positions and experimentally determining protonation states at near-physiological temperature. Our observations provide critical information for structure-assisted and computational drug design, allowing precise tailoring of inhibitors to the enzyme's electrostatic environment.

摘要

新型冠状病毒(SARS-CoV-2)的主要蛋白酶(3CL M)是病毒复制所必需的酶,也是引发 COVID-19 的病原体。3CL M 具有一个不寻常的催化双功能基,由半胱氨酸(Cys)和组氨酸(His)残基组成。该领域的一个关键问题是底物结合活性位点腔中可离子化残基的质子化状态是什么;解决这一问题将有助于了解酶的催化细节,并为针对这种恶性病毒的合理药物开发提供信息。在这里,我们呈现了 3CL M 的室温中子结构,该结构允许直接确定蛋白酶中活性位点的氢原子位置,从而确定质子化状态。我们观察到,催化位点天然采用两性离子反应形式,其中半胱氨酸呈带负电荷的硫醇盐状态,组氨酸呈双质子化和正电荷状态,而不是通常设想的中性非反应状态。中子结构还确定了所有其他氨基酸残基的质子化状态(因此是电荷状态),并揭示了活性位点腔中和二聚体界面处复杂的氢键网络。该结构中存在的精细原子细节是通过中子独特的散射特性实现的,中子是在接近生理温度下定位氢原子位置和实验确定质子化状态的理想探针。我们的观察结果为基于结构的和计算药物设计提供了关键信息,允许针对酶的静电环境精确调整抑制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/a98570fee927/SB-JBCJ200816F005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/2fbda39a07fa/SB-JBCJ200816F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/96d6e6a78dcf/SB-JBCJ200816F002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/1b6b7557913f/SB-JBCJ200816F003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/73b5dd73760c/SB-JBCJ200816F004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/a98570fee927/SB-JBCJ200816F005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/2fbda39a07fa/SB-JBCJ200816F001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/96d6e6a78dcf/SB-JBCJ200816F002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/1b6b7557913f/SB-JBCJ200816F003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/73b5dd73760c/SB-JBCJ200816F004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19dd/7863899/a98570fee927/SB-JBCJ200816F005.jpg

相似文献

1
Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography.中子晶体学揭示 SARS-CoV-2 主蛋白酶的非寻常两性离子催化位点。
J Biol Chem. 2020 Dec 11;295(50):17365-17373. doi: 10.1074/jbc.AC120.016154. Epub 2020 Oct 15.
2
Room-temperature neutron and X-ray data collection of 3CL M from SARS-CoV-2.来自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的3CL M的室温中子和X射线数据收集。
Acta Crystallogr F Struct Biol Commun. 2020 Oct 1;76(Pt 10):483-487. doi: 10.1107/S2053230X20011814. Epub 2020 Sep 15.
3
Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography.利用中子晶体学直接观察到 SARS-CoV-2 主蛋白酶在与抑制剂结合时的质子化状态变化。
J Med Chem. 2021 Apr 22;64(8):4991-5000. doi: 10.1021/acs.jmedchem.1c00058. Epub 2021 Mar 23.
4
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL main protease (Mpro) from proteomic identification of P6-P6' active site specificity.通过蛋白质组学鉴定 P6-P6' 活性位点特异性优化 SARS-CoV-2 3CL 主要蛋白酶(Mpro)的淬灭荧光肽底物
J Virol. 2024 Jun 13;98(6):e0004924. doi: 10.1128/jvi.00049-24. Epub 2024 May 14.
5
Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M: insights into enzyme mechanism and drug design.室温X射线晶体学揭示了新冠病毒3CL M中半胱氨酸残基的氧化和反应性:对酶机制和药物设计的见解
IUCrJ. 2020 Sep 21;7(Pt 6):1028-35. doi: 10.1107/S2052252520012634.
6
Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.SARS-CoV-2 和 SARS 冠状病毒 3CL 蛋白酶的别构调节作用在晶体结构组合中观察到。
J Mol Biol. 2021 Dec 3;433(24):167324. doi: 10.1016/j.jmb.2021.167324. Epub 2021 Oct 27.
7
High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.高通量虚拟筛选以发现冠状病毒 SARS-CoV-2 主要蛋白酶抑制剂。
Molecules. 2020 Jul 13;25(14):3193. doi: 10.3390/molecules25143193.
8
Structural plasticity of SARS-CoV-2 3CL M active site cavity revealed by room temperature X-ray crystallography.室温 X 射线晶体学揭示 SARS-CoV-2 3CL M 活性位点腔的结构可塑性。
Nat Commun. 2020 Jun 24;11(1):3202. doi: 10.1038/s41467-020-16954-7.
9
Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease.结构、电子和静电因素对 SARS-CoV-2 主蛋白酶中 S1 和 S2 亚基抑制剂结合的影响。
J Med Chem. 2021 Dec 9;64(23):17366-17383. doi: 10.1021/acs.jmedchem.1c01475. Epub 2021 Oct 27.
10
Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL through high-throughput virtual screening and molecular dynamics simulation.通过高通量虚拟筛选和分子动力学模拟筛选潜在的 FDA 批准的 SARS-CoV-2 主要蛋白酶 3CL 抑制剂。
Aging (Albany NY). 2021 Mar 7;13(5):6258-6272. doi: 10.18632/aging.202703.

引用本文的文献

1
Structure-based rational design of covalent probes.基于结构的共价探针合理设计。
Commun Chem. 2025 Aug 12;8(1):242. doi: 10.1038/s42004-025-01606-y.
2
Characterization of an unusual SARS-CoV-2 main protease natural variant exhibiting resistance to nirmatrelvir and ensitrelvir.一种对奈玛特韦和恩西特韦表现出抗性的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶天然变体的特征分析
Commun Biol. 2025 Jul 17;8(1):1061. doi: 10.1038/s42003-025-08487-w.
3
Prediction of enzyme inhibition (IC) using a combination of protein-ligand docking and semiempirical quantum mechanics.

本文引用的文献

1
Neutron macromolecular crystallography.中子大分子晶体学。
Emerg Top Life Sci. 2018 Apr 20;2(1):39-55. doi: 10.1042/ETLS20170083.
2
Room-temperature X-ray crystallography reveals the oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL M: insights into enzyme mechanism and drug design.室温X射线晶体学揭示了新冠病毒3CL M中半胱氨酸残基的氧化和反应性:对酶机制和药物设计的见解
IUCrJ. 2020 Sep 21;7(Pt 6):1028-35. doi: 10.1107/S2052252520012634.
3
Room-temperature neutron and X-ray data collection of 3CL M from SARS-CoV-2.
结合蛋白质-配体对接和半经验量子力学预测酶抑制作用(IC)
J Mol Model. 2025 Jul 12;31(8):209. doi: 10.1007/s00894-025-06423-7.
4
3CL of SARS-CoV-2 as a new target for bufadienolides: in silico and in vitro study.严重急性呼吸综合征冠状病毒2型的3CL作为蟾蜍二烯内酯的新靶点:计算机模拟和体外研究
J Comput Aided Mol Des. 2025 Jul 5;39(1):41. doi: 10.1007/s10822-025-00623-2.
5
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.揭示植物化学物质抑制新型冠状病毒M蛋白的潜力——基于计算机模拟和细胞的方法
Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.
6
A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats.关于利用分子模拟应对新冠疫情威胁的思考
J Phys Chem Lett. 2025 Apr 3;16(13):3249-3263. doi: 10.1021/acs.jpclett.4c03654. Epub 2025 Mar 21.
7
Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics.通过稳态和预稳态动力学确定的新型冠状病毒3-胰凝乳蛋白酶样蛋白酶的催化机制
ACS Catal. 2024 Nov 27;14(24):18292-18309. doi: 10.1021/acscatal.4c04695. eCollection 2024 Dec 20.
8
Visualizing the Active Site Oxyanion Loop Transition Upon Ensitrelvir Binding and Transient Dimerization of SARS-CoV-2 Main Protease.可视化恩赛特韦结合后 SARS-CoV-2 主蛋白酶活性位点氧阴离子环跃迁和瞬时二聚化。
J Mol Biol. 2024 Jul 1;436(13):168616. doi: 10.1016/j.jmb.2024.168616. Epub 2024 May 16.
9
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL main protease (Mpro) from proteomic identification of P6-P6' active site specificity.通过蛋白质组学鉴定 P6-P6' 活性位点特异性优化 SARS-CoV-2 3CL 主要蛋白酶(Mpro)的淬灭荧光肽底物
J Virol. 2024 Jun 13;98(6):e0004924. doi: 10.1128/jvi.00049-24. Epub 2024 May 14.
10
Neutron diffraction from a microgravity-grown crystal reveals the active site hydrogens of the internal aldimine form of tryptophan synthase.来自微重力生长晶体的中子衍射揭示了色氨酸合酶内部醛亚胺形式的活性位点氢原子。
Cell Rep Phys Sci. 2024 Feb 21;5(2). doi: 10.1016/j.xcrp.2024.101827. Epub 2024 Feb 12.
来自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的3CL M的室温中子和X射线数据收集。
Acta Crystallogr F Struct Biol Commun. 2020 Oct 1;76(Pt 10):483-487. doi: 10.1107/S2053230X20011814. Epub 2020 Sep 15.
4
The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic.2019新型冠状病毒(2019-nCoV):其进化及向人类的传播引发全球新冠疫情。
Int J Environ Sci Technol (Tehran). 2020;17(10):4381-4388. doi: 10.1007/s13762-020-02781-2. Epub 2020 May 26.
5
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.3C 样蛋白酶抑制剂可阻断冠状病毒在体外的复制,并改善 MERS-CoV 感染小鼠的存活率。
Sci Transl Med. 2020 Aug 19;12(557). doi: 10.1126/scitranslmed.abc5332. Epub 2020 Aug 3.
6
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.通过大规模化合物重新利用发现抗 SARS-CoV-2 病毒药物。
Nature. 2020 Oct;586(7827):113-119. doi: 10.1038/s41586-020-2577-1. Epub 2020 Jul 24.
7
Structural plasticity of SARS-CoV-2 3CL M active site cavity revealed by room temperature X-ray crystallography.室温 X 射线晶体学揭示 SARS-CoV-2 3CL M 活性位点腔的结构可塑性。
Nat Commun. 2020 Jun 24;11(1):3202. doi: 10.1038/s41467-020-16954-7.
8
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease.博赛匹韦、GC-376 和钙蛋白酶抑制剂 II、XII 通过靶向病毒主蛋白酶抑制 SARS-CoV-2 病毒复制。
Cell Res. 2020 Aug;30(8):678-692. doi: 10.1038/s41422-020-0356-z. Epub 2020 Jun 15.
9
Covid-19: a comprehensive review of a formidable foe and the road ahead.Covid-19:一个强大敌人的全面综述及未来之路。
Expert Rev Respir Med. 2020 Sep;14(9):869-879. doi: 10.1080/17476348.2020.1782198. Epub 2020 Jun 30.
10
COVID-19: Drug Targets and Potential Treatments.新型冠状病毒肺炎:药物靶点与潜在治疗方法。
J Med Chem. 2020 Nov 12;63(21):12359-12386. doi: 10.1021/acs.jmedchem.0c00606. Epub 2020 Jun 26.